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ABSTRACT
C57BL/6J (C57) and DBA/2J (DBA) mice respond differently to
drugs that affect dopamine systems, including alcohol. The
current study compared effects of D1 and D2 receptor agonists
and antagonists, and the interaction between D1/D2 antagonists
and alcohol, on intracranial self-stimulation in male C57 and
DBA mice to determine the role of dopamine receptors in the
effects of alcohol on brain stimulation reward (BSR). In the initial
strain comparison, dose effects on BSR thresholds andmaximum
operant response rates were determined for the D1 receptor
agonist SKF-82958 (6-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-
2,3,4,5-tetrahydro-1H-3-benzazepine; 0.1–0.56 mg/kg) and
antagonist SCH 23390 (1-7-chloro-8-hydroxy-3-methyl-1-phenyl-
2,3,4,5-tetrahydro-1H-3-benzazepinehydrochloride; 0.003–0.056
mg/kg), and the D2 receptor agonist quinpirole (0.1–3.0 mg/kg)
and antagonist raclopride (0.01–0.56 mg/kg). For the alcohol
interaction, SCH 23390 (0.003 mg/kg) or raclopride (0.03 mg/kg)
was given before alcohol (0.6–2.4 g/kg p.o.). D1 antagonism
dose-dependently elevated and SKF-82958 dose-dependently
lowered BSR threshold in both strains; DBA mice were more sen-
sitive to SKF-82958 effects. D2 antagonism dose-dependently
elevated BSR threshold only in C57 mice. Low doses of quinpirole
elevated BSR threshold equally in both strains, whereas higher
doses of quinpirole lowered BSR threshold only in C57 mice. SCH
23390, but not raclopride, prevented lowering of BSR threshold by
alcohol in DBA mice. Conversely, raclopride, but not SCH 23390,
prevented alcohol potentiation of BSR in C57 mice. These results
extend C57 and DBA strain differences to D1/D2 sensitivity of
BSR, and suggest differential involvement of D1 and D2 receptors
in the acute rewarding effects of alcohol in these two mouse
strains.
Introduction
Intracranial self-stimulation (ICSS) is a valuable behavioral
method to understand the role of dopamine in reward-related
behaviors. ICSS measures the responding of an animal rein-
forced by electrical stimulation of mesolimbic reward circuitry,
which ultimately increases activity of dopaminergic projections
from the ventral tegmental area (VTA) to the nucleus ac-
cumbens (NAc). Brain stimulation reward (BSR) is exquisitely
sensitive tomanipulation of dopamine (DA) receptors (Kornetsky
and Bain, 1992; Wise, 1996). By activating the dopaminergic
system, drugs of abuse, including alcohol, potentiate BSR,
whereas drugs that decrease dopaminergic activity decrease
BSR.
C57BL/6J (C57) and DBA/2J (DBA) mice exhibit differences
in dopamine systems (Crawley et al., 1997; Puglisi-Allegra
and Cabib, 1997). Compared with C57 mice, DBA mice have
more neurons expressing tyrosine hydroxylase (TH) in the
VTA and substantia nigra pars compacta, increased dopamine
transporter expression in the prefrontal cortex, a more discrete
distribution of dopamine transporter and TH immunoreactive
fibers in the NAc, higher density of TH-immunoreactive fibers
in the prefrontal cortex, lower density of D1 and D2 receptors
in the striatum, and greater density of D2 receptors in the
midbrain (Ng et al., 1994; Zocchi et al., 1998; D’Este et al.,
2007). Amphetamine and cocaine stimulate greater DA release
in the NAc and more locomotor activity in C57 than in DBA
mice (Cabib et al., 2000; Ventura et al., 2004; Orsini et al.,
2005). DBA mice may also have increased D2 autoreceptor
activity (Puglisi-Allegra and Cabib, 1997) given their greater
sensitivity to apomorphine inhibition of DAmetabolism (Cabib
and Puglisi-Allegra, 1991) and quinpirole- and haloperidol-
induced catalepsy (Kanes et al., 1993; Puglisi-Allegra and
Cabib, 1997).
Two previous studies have directly compared ICSS in C57
and DBA mice. Both strains had similar BSR thresholds
(Elmer et al., 2010; Fish et al., 2010) and no strain difference
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was found in amphetamine potency (Elmer et al., 2010); however,
DBA mice were more sensitive to the threshold lowering effects
of cocaine (Fish et al., 2010). Additionally, the two strains were
differentially sensitive to morphine and alcohol. Morphine low-
ered BSR thresholds in C57 and elevated thresholds in DBAmice
(Elmer et al., 2010), whereas high doses of alcohol lowered
thresholds in DBA and elevated thresholds in C57 mice (Fish
et al., 2010). This latter difference is consistent with other dem-
onstrations that these strains respond uniquely to alcohol. For
example, although DBAmice voluntarily drinkmuch less alcohol
due to an innate taste or olfactory aversion (Belknap et al., 1977;
Grahame and Cunningham, 1997), they show increased locomo-
tor activation and sensitization (Crabbe et al., 1982; Phillips et al.,
1994), conditioned place preference (Cunningham et al., 1992b),
and dopamine release (Kapasova andSzumlinski, 2008) following
parenteral alcohol administration, and increased VTA cell firing
in vitro (Brodie and Appel, 2000;McDaid et al., 2008). Differences
in the mesolimbic dopamine system may underlie differences in
the behavioral effects of alcohol in these two inbred strains.
C57micewith reducedD1 orD2 receptor expression consume
less alcohol (El-Ghundi et al., 1998; Phillips et al., 1998;
Risinger et al., 2000; Bahi and Dreyer, 2012), whereas mice
lacking D2 receptors also have reduced alcohol place preference
(Cunningham et al., 2000). D2 antagonists can block alcohol
self-administration in rats (Slawecki et al., 1997; Samson and
Chappell, 1999), locomotor stimulation in several lines of mice
(Shen et al., 1995; Broadbent et al., 2005; Pastor et al., 2005;
Abrahao et al., 2012), and conditioned taste aversion in outbred
Swiss-Webster mice (Risinger et al., 1999), but not conditioned
place preference in DBA mice (Cunningham et al., 1992a;
Risinger et al., 1992).
The present study had two objectives: to compare the sen-
sitivity of BSR in C57 and DBA mice to D1 and D2 receptor
agonists and antagonists, and to compare the potency of D1 or
D2 receptor antagonists to reduce the reward-potentiating
effects of alcohol in these strains. We hypothesized that BSR
thresholds would be lowered by the D1 receptor agonist SKF-
82958 (6-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetra-
hydro-1H-3-benzazepine) and by higher doses of theD2 receptor
agonist quinpirole, whereas the D1 receptor antagonist SCH
23390 (1-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetra-
hydro-1H-3-benzazepinehydrochloride) and the D2 receptor
antagonist raclopride would elevate BSR thresholds. Based
on previous demonstrations that DBAmice have enhanced D2
function, we hypothesized they would be more sensitive to the
threshold-lowering effect of quinpirole and less sensitive to the
threshold-elevating effect of raclopride than C57 mice. Because
of the role of dopamine in alcohol reward, we hypothesized that
D1 and D2 antagonists would attenuate the BSR threshold-
lowering effects of alcohol.
Materials and Methods
Mice. Male C57BL/6J (n 5 35) and DBA/2J (n 5 24) mice (The
Jackson Laboratory, Bar Harbor, ME) arrived weighing at least 22 g
and were housed in polycarbonate cages (28  17  14 cm) lined with
cob bedding that was changed weekly, and covered with stainless
steel wire lids for free access to dry chow and tap water. The vivarium
was 21 6 1°C, 30–40% humidity, and on a 12-hour dark/light cycle
(lights off at 8:00 AM). All procedures were performed during the dark
phase, approved by the Institutional Animal Care andUse Committee
(IACUC) of theUniversity of North Carolina, and conducted according
to the Guide for the Care and Use of Laboratory Animals (National
Institutes of Health publication No. 85-23, revised 2011).
After a week of acclimation to the vivarium, the mice were anes-
thetized with intraperitoneal ketamine [(6)-2-2-(2-chlorophenyl)-2-
(methylamino)cyclohexanone hydrochloride, 120 mg/kg] and xylazine
[2-(2,6-dimethylphenylamino)-5,6-dihydro-4H-thiazine hydrochloride,
9 mg/kg] (Sigma-Aldrich, St. Louis, MO) and stereotaxically implanted
with insulated monopolar stainless steel electrodes (0.28 mm diameter;
Plastics One, Roanoke, VA) aimed at the right medial forebrain bundle
at the level of the lateral hypothalamus (AP:21.2; ML:21.0; DV:25.2),
using coordinates from Paxinos and Franklin (2008). The electrode was
connected to a stainless steel electrical ground screw and mounted to
the skull with dental cement. Following surgery, the mice were housed
individually.
Apparatus and Procedures. Similar to previous descriptions
(Malanga et al., 2008; Fish et al., 2010), sound-attenuated operant
conditioning chambers interfaced to computers running software
(MED-PC for Windows, version 4.1; Med Associates, St. Albans, VT)
that recorded wheel spins, controlled house lights, and issued current to
electrodes connected through a swivel commutator and insulated wire
(Plastics One). Each one-quarter turn of a wheel manipulandum was
reinforced by a brief (500 milliseconds) unipolar cathodal square-wave
current at a frequency of 158 Hz (pulse width 5 100 microseconds)
accompanied by illumination of the house light (500 milliseconds).
Responses in the 500-millisecond stimulation period were recorded but
did not earn additional stimulation. Current intensity was adjusted for
each individual mouse and held constant throughout the experiment to
maintain at least 40 responses/min (240 to 2180 mA). Mice responded
for a series of 15 decreasing (0.05 log10) stimulation frequencies, each
available for 1 minute beginning with a 10-second phase during which
5 noncontingent (“priming”) stimulations were presented. During con-
ditioning, each frequency series was presented four times (60-minute
session) and the range was adjusted such that mice responded only
during the three to seven highest frequencies. The primary dependent
variable, the threshold frequency to maintain responding (BSR
threshold; u0), was defined as the x-intercept of the least-squares
regression line through frequencies that sustained 20, 30, 40, 50, and
60% of the maximal response rate as described by Coulombe and
Miliaressis (1987), Rompré and Wise (1989), and reviewed by Carlezon
andChartoff (2007), and was calculated with custom-designed software.
When thresholds varied less than 10% on three consecutive days, the
mice were habituated to injections and drug-testing phases began.
Comparison of electrical charge delivery (Q, in coulombs) at BSR
threshold (u0) between strains (Fig. 1) was performed before pharma-
cological experiments, where Q 5 A  t, or stimulus intensity (in
amperes)  duration of current application (in seconds).
Each test session began with a 45-minute preinjection period con-
sisting of three series of 15 descending frequencies, and daily baseline
parameters were calculated from the average of the second and third
series. Results from each 15-minute series after drug or vehicle injection
were expressed as a percentage of the daily preinjection baseline. For all
dose-effect studies, the mice were removed from the chamber, injected,
and returned immediately for four series of 15 descending stimulation
frequencies. Eleven C57 and 10 DBA mice received each dose of SKF-
82958 (saline, 0.1–0.56mg/kg) andSCH23390 (saline, 0.003–0.056mg/kg).
Thirteen C57 and nine DBA mice received each dose of quinpirole
(saline, 0.1–3.0 mg/kg) and raclopride (saline, 0.01–0.56 mg/kg). The
order of each drug dose was counterbalanced across the mice, and each
drug dose was separated by a vehicle injection and at least 48 hours.
The ethyl alcohol (ethanol; hereafter, alcohol) and DA receptor
antagonist interaction studies were conducted in 17 C57 and 11 DBA
mice. Six of the C57 and six of the DBA mice had previously completed
the quinpirole and raclopride studies whereas the remaining 11 C57
and fiveDBAmice had no previous treatment history. After preinjection
baseline responding, the mice were injected with saline, SCH 23390
(0.003 mg/kg), or raclopride (0.03 mg/kg), returned to their home cage
for 15 minutes, orally gavaged with alcohol (0.3–2.4 g/kg), and placed
immediately into the ICSS chamber as previously described (Fish et al.,
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2010, 2012). Six C57 and two DBA mice completed studies with both
SCH 23390 and raclopride and alcohol. Two C57 and four DBA mice
completed studies with alcohol and raclopride only. Nine C57 and five
DBA mice completed studies with alcohol and SCH 23390 only.
Drugs. Ethyl alcohol solutions were prepared (w/v) in tap water
and injected via oral gavage through a stainless steel feeding tube in
a volume of 1 ml/100 g body weight. The D1 receptor agonist, SKF-
82958 (Sigma-Aldrich), D1 antagonist SCH 23390 (Sigma-Aldrich),
D2 agonist quinpirole [(4aR-trans)-4,4a,5,6,7,8,8a,9-octahydro-5-
propyl-1H-pyrazolo[3,4-g] quinolone hydrochloride; Tocris Bioscience,
Bristol, UK], and D2 antagonist raclopride [3,5-dichloro-N-(1-ethyl-
pyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxybenzamide(1)-tartrate
salt; Sigma-Aldrich] were dissolved in 0.9% saline and injected in-
traperitoneally through a 27-gauge needle. All doses were calculated as
the free base.
Histology. Brains from mice used for ICSS experiments were
fixed by intracardiac perfusion with 4% paraformaldehyde in 0.1 M
phosphate-buffered saline under deep pentobarbital anesthesia, re-
moved, sectioned, and stained with cresyl violet for Nissl to determine
electrode placements. Themost ventral point of each electrode tract in
the lateral hypothalamus was determined by visual inspection under
low-power (10) microscopy. All ICSS electrodes were implanted in
the right lateral hypothalamus.
Data Analysis. Baseline threshold and maximum response rates
were compared between C57 and DBA mice using unpaired t tests.
For the dose-effect studies, the threshold and the maximum operant
response rate (MAX) from the final 45 minutes were averaged into
a single value for each drug. Quinpirole had a biphasic effect on
threshold and MAX, and the data from the first 15 minutes after
injection were analyzed separately. The dose-effect studies for the D1
and D2 receptor agonists and antagonists were compared between
C57 and DBA mice using two-way mixed-measures analysis of
variance with strain as the between-subjects factor and drug dose
as the within-subjects factor. The D1 and D2 receptor antagonist
interaction with alcohol was analyzed separately in C57 and DBA
mice using two-way repeated-measures analysis of variance with both
alcohol dose and antagonist dose as within-subjects factors. Signifi-
cant F tests were analyzed post hoc using Bonferroni-corrected tests
compared with a common control.
Results
Baseline ICSS Responding. C57 andDBAmice responded
for ICSS in a frequency-dependent manner, with higher fre-
quencies supporting higher response rates (Fig. 1A). Although
there was no difference in the charge sustaining responding at
BSR threshold between strains (t57 5 0.89; P 5 0.38; Fig. 1B),
DBA mice had a significantly lower MAX than C57 mice (t57 5
4.5; P , 0.001; Fig. 1C). Placements of ICSS electrodes were
similar in both mouse strains (Fig. 2).
SKF-82958 and SCH 23390. For the D1 receptor agonist
SKF-82958, there were significant main effects of drug dose
(F4,104 5 6.4; P , 0.001) and mouse strain (F1,104 5 6.1; P 5
0.02) on BSR threshold (Fig. 3A). There was no significant
interaction between SKF-82958 dose and mouse strain on
threshold (P 5 0.18). In C57 mice, the 0.1 and 0.17 mg/kg
SKF-82958 doses lowered threshold, whereas in DBA mice,
the 0.17, 0.3, and 0.56 mg/kg doses lowered threshold. The 0.3
and 0.56 mg/kg doses lowered threshold more in DBA mice
than in C57 mice. There was a significant interaction between
SKF-82958 dose and mouse strain on MAX (F4,104 5 2.7; P 5
0.04; Fig. 3C). The 0.1 and 0.17 mg/kg doses increasedMAX in
C57 mice but not DBA mice. The 0.56 mg/kg dose suppressed
MAX in C57 but not in DBA mice.
For the D1 receptor antagonist SCH 23390, there was a
significant main effect of drug dose on BSR threshold (F4,99 5
10.1;P, 0.001; Fig. 3B). In bothmouse strains, the 0.056mg/kg
dose of SCH 23390 significantly elevated threshold. There
was nomain effect of mouse strain and no interaction between
mouse strain and SCH 23390 dose. There were significant
main effects of SCH 23390 dose (F4,99 5 21.0; P , 0.001) and
mouse strain (F1,99 5 13.5; P 5 0.002), but no significant
interaction between SCH 23390 dose and strain (P 5 0.18) on
MAX (Fig. 3D). In C57 mice, the 0.01, 0.03, and 0.056 mg/kg
doses of SCH 23390 reduced MAX response rates, whereas
only the 0.056 mg/kg dose reduced MAX response rates in
DBA mice. The 0.1, 0.3, and 0.56 doses suppressed MAX more
in C57 mice than in DBA mice.
Quinpirole and Raclopride. For the D2 receptor agonist
quinpirole, there was a significant main effect of drug dose on
BSR threshold in the first 15 minutes after administration
(F5,1215 6.7; P, 0.001; Table 1). In C57mice, the 0.3, 1.0, and
3.0 mg/kg doses elevated threshold, whereas in the DBAmice,
the 0.3 and 1.0 mg/kg doses elevated threshold. There was no
main effect of mouse strain and no interaction between quin-
pirole dose and mouse strain. There was a significant inter-
action between quinpirole dose andmouse strain onMAX in the
first 15 minutes after administration (F5,121 5 5.0; P , 0.001;
Table 1). In both mouse strains, the 1.0 and 3.0 mg/kg doses
suppressed MAX response rate. After the first 15 minutes of
quinpirole administration, there was a significant interaction
Fig. 1. Baseline ICSS performance in C57BL/6J and DBA/2J mice. (Left) Both C57 (black circles) and DBA mice (gray triangles) responded for BSR in
a frequency-dependent manner. Values are the mean number of responses per 50-second access to BSR at each stimulus frequency 6S.E.M. (Center)
BSR sensitivity expressed as electrical charge delivery at BSR threshold frequency (u0) did not differ between C57 (black bars) and DBAmice (gray bars).
Values are the mean charge in coulombs 6S.E.M. (Right) Baseline maximum operant response rates were lower in DBA mice (gray bars) than in C57
mice (black bars). Values are the mean maximum number of responses 6 S.E.M. *P , 0.05 versus C57.
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between drug dose andmouse strain on BSR threshold (F5,1215
10.1; P , 0.001; Fig. 4A). In C57 mice, the 0.1 mg/kg dose
elevated threshold and the 3.0 mg/kg dose lowered threshold,
whereas in DBA mice, the 0.3, 0.56, 1.0, and 3.0 mg/kg doses
elevated threshold. The effects of the 0.56, 1.0, and 3.0 mg/kg
doses on threshold were significantly different between C57 and
DBA mice. There was also a significant interaction between
quinpirole dose and mouse strain on MAX (F5,121 5 9.1; P #
0.001). In C57 mice, all quinpirole doses suppressed MAX, and
in DBA mice, all quinpirole doses except 0.1 mg/kg suppressed
MAX (Fig. 4C). The suppression of MAX was greater in C57
mice after the 0.1 mg/kg dose and greater in DBAmice after the
0.56 and 1.0 mg/kg doses.
For the D2 receptor antagonist raclopride, there were sig-
nificant main effects of drug dose (F5,125 5 11.0; P, 0.001) and
mouse strain (F1,125 5 7.5; P 5 0.01) on BSR threshold. There
was a trend for an interaction between mouse strain and
raclopride dose onBSR threshold that did not reach significance
(P 5 0.08). In C57 mice, the 0.3 and 0.56 mg/kg doses of
raclopride elevated threshold (Fig. 4B), and the 0.1, 0.3, and
0.56 mg/kg doses elevated threshold more in C57 mice than in
DBA mice. There were significant main effects of raclopride
dose (F5,125 5 17.8; P , 0.001) and mouse strain (F1,125 5 10.1;
P5 0.005) onMAX (Fig. 4D). There was no interaction between
raclopride dose and mouse strain on MAX (P 5 0.99). In C57
mice, the 0.3 and 0.56 mg/kg raclopride doses suppressed MAX,
whereas the 0.56 mg/kg dose suppressed MAX in DBA mice.
SCH 23390 and Alcohol. In C57 mice, there were sig-
nificant main effects of alcohol on BSR threshold (F4,149 5 4.5;
P 5 0.003; Fig. 5A) and MAX (F4,149 5 6.9; P , 0.001; Fig. 5C),
but nomain effect of SCH23390 pretreatment and no interaction
between SCH 23390 pretreatment and alcohol dose. Regardless
of pretreatment with SCH 23390, the 0.6 g/kg alcohol dose
lowered threshold,whereas the 1.7 and 2.4 g/kg doses suppressed
MAX. In DBA mice, there was a significant interaction between
SCH 23390 pretreatment and alcohol dose on BSR threshold
(F4,695 4.1; P5 0.01; Fig. 5B). The 1.7 and 2.4 g/kg alcohol doses
significantly lowered threshold following saline pretreatment,
but not following SCH 23390 pretreatment. The effects of these
alcohol doses were significantly different following saline or
SCH 23390 pretreatment. There was a significant main effect
of 1.0 g/kg alcohol on MAX (F4,69 5 2.9; P 5 0.04; Fig. 5D).
Raclopride and Alcohol. In C57 mice, there was a signif-
icant interaction between raclopride pretreatment and alcohol
dose on BSR threshold (F4,79 5 7.0; P , 0.001; Fig. 6A) and
MAX (F4,79 5 2.9; P 5 0.04; Fig. 6C). The 0.6 g/kg alcohol dose
significantly lowered threshold following saline pretreatment.
Following raclopride pretreatment, the 1.0 g/kg alcohol dose
significantly elevated threshold and trended toward elevating
threshold after the 0.6 g/kg dose (P 5 0.059). Raclopride
significantly altered the effects of the 0.6 and 1.0 g/kg alcohol
doses, but did not alter the effects of the 1.7 and 2.4 g/kg alcohol
doses.Whereas no dose of alcohol significantly affected MAX in
C57 mice, raclopride pretreatment significantly reduced the
effects of the 1.0 g/kg alcohol dose and trended toward reducing
the effects of the 0.6 g/kg dose (P 5 0.053). In DBA mice, there
was a significantmain effect of alcohol onBSR threshold (F4,595
5.0; P 5 0.006; Fig. 6B). There was no significant interaction
between raclopride pretreatment and alcohol dose (P 5 0.28);
Fig. 2. Schematic representation of ICSS electrode tip placements in
C57BL/6J and DBA/2J mice. All ICSS electrodes were implanted on the
right. Tip positions are plotted on the left for C57 (black circles) and on the
right for DBA mice (gray triangles) for clarity.
Fig. 3. Effects of a dopamine D1 receptor agonist, SKF-82958, and D1
receptor antagonist, SCH 23390, on ICSS performance in C57BL/6J and
DBA/2J mice. Changes in BSR threshold (A and B) and MAX (C and D)
after injection of SKF-82958 (open symbols) or SCH 23390 (filled symbols)
are shown for C57 (circles) and DBA mice (triangles). DBA mice were
generally more sensitive to the reward-potentiating effects of the D1
agonist than C57 mice (A). The dose-response curve of SCH 23390 onMAX
(D), but not BSR threshold (B), was shifted to the left with an increase in
maximum response over the dose range tested (0.003–0.56 mg/kg i.p.) in
C57 mice relative to DBA mice. Values are expressed as the mean
percentages of preinjection baselines (6 S.E.M.) averaged across the final
45 minutes after drug injection. P values for significant main effects of
strain and drug dose are inset as text. *Significance versus vehicle (V)
(,0.05); †significance versus DBA mice (,0.05).
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however, post-hoc analysis of the main effect showed that the
1.0 and 1.7 g/kg alcohol doses lowered threshold. There was
a significant interaction between raclopride pretreatment and
alcohol dose on MAX (F4,59 5 3.4; P 5 0.03; Fig. 6D). Where-
as no alcohol dose significantly affected MAX in DBA mice,
raclopride pretreatment significantly reduced the effects of the
1.7 and 2.4 g/kg alcohol doses.
Discussion
These data provide evidence for a difference in the contribu-
tions of dopamineD1andD2 receptor activity toBSR in the C57
and DBA mouse strains. DBA mice were more sensitive to
effects of the D1 agonist SKF-82958 and less sensitive to effects
of the D2 receptor antagonist raclopride and the D2 agonist
quinpirole. These data confirm previous strain differences
in dopaminergic modulation of locomotor activity, prepulse
inhibition (PPI), learning, and memory (Puglisi-Allegra and
Cabib, 1997; Ralph and Caine, 2005) and extend them to a
direct behavioral measure of reward. These data also replicate
our previously observed strain difference in alcohol effects on
ICSS (Fish et al., 2010), in that alcohol has greater potency to
lower BSR threshold in DBA than C57 mice. A low dose of the
D1 antagonist SCH 23390 blocked the reward-potentiating
effects of alcohol on BSR in the DBA strain, but had no effect in
the C57 strain. In contrast, a low dose of the D2 antagonist
raclopride blocked the reward-potentiating effects of alcohol on
BSR in the C57 strain, but not in the DBA strain. This suggests
that D1 andD2 receptor signalingmay contribute differently to
the rewarding effects of alcohol in C57 and DBA mice.
D1 receptor agonists modulate BSR, although inconsistently
across species and procedure (Nakajima and O’Regan, 1991;
Hunt et al., 1994; Ranaldi and Beninger, 1994; Baldo et al.,
1999; Malanga et al., 2008). Mice lacking D1 receptors have
deficient ICSS performance (Tran et al., 2005). Across a dose
range similar to previous studies in outbred Swiss-Webster
mice, SKF-82958 lowered BSR threshold in both C57 and DBA
mice, but had greater efficacy in DBA mice. Consistent with
previous rat studies (Panagis and Spyraki, 1996; Sundstrom
et al., 2002; Cheer et al., 2007), the D1 antagonist SCH 23390
elevated threshold equally in both strains, but the potency of
SCH 23390 to decrease maximum response rates was lower in
DBA mice, indicating that the strain difference was specific to
a measure of operant performance. It is generally regarded by
most investigators that, although some degree of overlap in the
neural circuits mediating motor activation and reward percep-
tion exists, operant response rate per se is more closely tied to
activation or inhibition of motor output and BSR threshold to
the perceived value of the reward. Although statistically sig-
nificant, the overall D1-related pharmacological differences
between C57 and DBA mice were modest, suggesting that D1
receptor activitymay have a relatively smaller role in the dopa-
minergic differences of the two strains. Radioligand binding
studies have shown small strain differences in D1 receptors
Fig. 4. Effects of a dopamine D2 receptor agonist, quinpirole, and D2
receptor antagonist, raclopride, on ICSS performance in C57BL/6J and
DBA/2J mice. Changes in BSR threshold (A and B) and MAX (C and D)
after injection of quinpirole (open symbols) or raclopride (filled symbols)
are shown for C57 (circles) and DBA mice (triangles). Biphasic effects of
quinpirole on BSR threshold were found, with elevations at lower doses
(0.1 mg/kg i.p.) and reduction of threshold at the highest dose tested
(3.0mg/kg i.p.) in C57mice, whereas consistent elevations of BSR threshold
to quinpirole were seen in DBA mice (A). In contrast, dose-dependent
elevations in BSR threshold after raclopride were found in C57 but not
DBA mice (B). Reduction in MAX was found across most quinpirole doses
(C) and at the highest dose of raclopride tested (0.56 mg/kg i.p.) (D) in
both mouse strains. Values are expressed as the mean percentages of
preinjection baselines (6 S.E.M.) averaged across the final 45 minutes
after drug injection. P values for significant main effects of strain and drug
dose are inset as text. *Significance versus vehicle (V) (,0.05); †signifi-
cance versus DBA mice (,0.05).
TABLE 1
Effects of quinpirole on ICSS responding in minutes 0–15 after injection
All data are the mean percentage of preinjection baseline (6 S.E.M.).
Dose
VEH 0.1 0.3 0.56 1.0 3.0
mg/kg
BSR threshold
C57 111 6 3.8 140 6 11 174 6 19* 144 6 10 155 6 12* 162 6 5.6*
DBA 115 6 5.3 96.6 6 9.4 160 6 17* 144 6 21 159 6 13* 137 6 13
MAX response rate
C57 79.6 6 3.8 59.0 6 7.6 66.7 6 3.7 60.0 6 12 49.6 6 5.2* 28.7 6 2.8*
DBA 86.5 6 3.0 112 6 8.6† 62.8 6 8.6 45.5 6 6.9 31.9 6 6.6* 29.7 6 10.2*
VEH, vehicle.
*Post hoc significance versus vehicle (P , 0.05).
†Post hoc significance versus C57 (P , 0.05).
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that suggestmoreD1-like receptors in the striatum of C57mice
(Ng et al., 1994; Puglisi-Allegra and Cabib, 1997). A strain
comparison of D1 effects on PPI, a measure of sensorimotor
gating, showed that the agonist R-6-Br-APB decreased PPI in
C57 mice and had no effect in DBA mice (Ralph and Caine,
2005), whereas it more potently stimulated locomotor activity
in DBA mice (Thomsen et al., 2011). Together with our ICSS
data, it is reasonable to conclude that strain differences in
response to D1 receptor activity are behaviorally specific.
In contrast to D1 sensitivity, the C57 and DBA strain dif-
ference was more pronounced after treatment with the D2
agonist, quinpirole, and the D2 antagonist, raclopride. Quin-
pirole had dose- and time-dependent effects on threshold and
MAX consistent with previous observations (Hatcher and
Hagan, 1998; Malanga et al., 2008). In both C57 and DBA
strains, quinpirole elevated threshold and suppressed MAX in
the first 15 minutes after administration. After this initial
phase, higher quinpirole doses lowered BSR threshold in C57
but not in DBA mice, which also showed a greater suppression
of MAX. This strain difference in response to quinpirole is
consistent with differences in locomotor activity, catalepsy, and
social behavior (Puglisi-Allegra and Cabib, 1997). Quinpirole is
thought to act in a concentration-dependent manner, with low
concentrations acting at presynaptic D2 autoreceptors and
higher concentrations activating postsynaptic D2 receptors
(White andWang, 1986). Quinpirole elevated but did not lower
BSR threshold in DBA mice, suggesting that this strain may
have enhanced D2 autoreceptor and/or decreased postsynaptic
D2 sensitivity, consistent with previous findings that D2-like
receptor binding and mRNA expression are greater in the VTA
and substantia nigra pars compacta and lower in the striatum
of DBA compared with C57 mice (Ng et al., 1994; Cabib et al.,
1998). In both strains, raclopride elevated thresholds and re-
duced MAX in a dose range similar to previous studies in C57
mice (Riday et al., 2012), and more potently in C57 than DBA
mice, which is inconsistent with data on haloperidol-induced
catalepsy (Kanes et al., 1993) and suppression of sucrose
drinking by raclopride (Dym et al., 2009). Taken together, the
differences in responses to quinpirole and raclopride suggest
that, regarding reward-related behavior in both C57 and DBA
strains, D2 receptors may contribute more than D1 receptors.
The effects of alcohol differed in the C57 and DBA strains,
and were consistent with our previous comparison (Fish et al.,
2010); the 0.6 g/kg dose produced a small but significant
reduction in the threshold of C57 mice, whereas the 1.7 and
2.4 g/kg doses reduced threshold in DBA mice. MAX tended to
be suppressed by the highest alcohol doses in C57 mice, but
was modestly increased by the higher alcohol doses in the DBA
mice. Based on initial dose-effect determinations, a low dose of
SCH 23390 or raclopride, which had no behavioral effects on its
own, was then administered before alcohol. In C57 mice, SCH
Fig. 5. Interaction between a low dose of a dopamine D1 receptor
antagonist, SCH 23390, and different doses of alcohol on ICSS perfor-
mance in C57BL/6J and DBA/2J mice. Changes in BSR threshold (A and
B) and MAX (C and D) after gavage with water (vertical bars) or alcohol
(symbols) following i.p. injection with saline (Sal; open symbols) or the
0.003 mg/kg dose of SCH 23390 (SCH; filled symbols) are shown for C57
(circles) and DBA mice (triangles). The D1 antagonist SCH 23390 had no
significant effect on alcohol in C57 mice (A), but completely blocked the
reward-potentiating effect of alcohol in DBA mice (B). Values are ex-
pressed as the mean percentages of preinjection baselines (6 S.E.M.) in
the first 15 minutes after alcohol or water. In panels in which no signifi-
cant interaction effects of SCH 23390 and alcohol are seen, P values for
significant main effects of alcohol are inset as text. Numbers within the
vertical bars indicate the number of C57 and DBA mice tested. *Signifi-
cance versus water (H2O) (,0.05);
†significance versus saline pretreat-
ment (,0.05).
Fig. 6. Interaction between a low dose of a dopamine D2 receptor an-
tagonist, raclopride, and different doses of alcohol on ICSS performance in
C57BL/6J and DBA/2J mice. Changes in BSR threshold (A and B) and
MAX (C and D) after gavage with water (vertical bars) or alcohol (symbols)
following i.p. injection with saline (Sal; open symbols) or the 0.03 mg/kg
dose of raclopride (Rac; filled symbols) are shown for C57 (circles) and DBA
mice (triangles). The D2 antagonist raclopride blocked and reversed the
reward-potentiating effect of low-dose (0.6 mg/kg) alcohol in C57 mice (A),
but did not affect alcohol potentiation of BSR in DBA mice (B). Values are
expressed as the mean percentages of preinjection baselines (6 S.E.M.) in
the first 15 minutes after alcohol or water. In panels in which no signifi-
cant interaction effects of raclopride and alcohol are seen, P values for
significant main effects of alcohol are inset as text. *Significance versus
water (H2O) (,0.05);
†significance versus saline pretreatment (,0.05).
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23390 did not alter the effects of any dose of alcohol tested on
BSR threshold. However, raclopride significantly altered the
effects of 0.6 and 1.0 g/kg alcohol. In the presence of raclopride,
these alcohol doses elevated, rather than lowered, BSR thresh-
olds in C57 mice. In contrast, SCH 23390 prevented the
threshold-lowering effects of 1.7 and 2.4 g/kg alcohol in DBA
mice, whereas raclopride did not alter the effects of these alcohol
doses. Although raclopride appeared to enhance the threshold-
lowering effects of 1.0 g/kg alcohol, there was no significant
overall interaction between raclopride and alcohol. Taken
together, these results suggest that D2 receptor activity contrib-
utes relatively more than D1 activity to the rewarding effects of
alcohol in C57mice; conversely, D1 activity contributes relatively
more than D2 activity to alcohol reward in DBA mice. This does
not, however, translate directly to the effects of dopamine recep-
tor activity on voluntary oral alcohol intake in the two strains,
comparison of which is unavoidably confounded by an innate
taste aversion to alcohol in DBA mice (Belknap et al., 1977;
Grahame and Cunningham, 1997) that is bypassed in our study.
An important consideration is that only very low doses of
SCH-23390 (0.003 mg/kg) and raclopride (0.03 mg/kg) were
given in combination with alcohol. The rationale was that
these doses had no independent effects on either BSR thresh-
olds orMAX. Higher doses of each antagonist may have altered
the reward-potentiating effects of alcohol in both strains, but
would be more difficult to interpret due to confounding effects,
such as locomotor suppression. Also, systemic administration
does not address the role of DA receptors in specific brain
regions, which may be particularly important for D2 receptors
and may be relevant to strain differences. As observed by
Elmer et al. (2010), ICSS is not as reliable in the DBA strain as
in other mouse strains, even at comparable stimulation sites.
The previously described functional anatomic differences in the
mesocorticolimbic dopaminergic systems of C57 and DBAmice
(D’Este et al., 2007) may have a pronounced impact on reward-
related behavior measured by ICSS.
Our current findings support the hypotheses that DA acting
at both D1 and D2 receptors contributes to brain stimulation
reward, and that mouse strains differ in the contribution of
signaling through these two receptors. D1 and D2 receptors
are also involved in BSR potentiation by alcohol, and it is
likely that the mesolimbic DA system contributes to the
rewarding and reinforcing effects of acute alcohol. Blunting
the rewarding and reward-enhancing effects of acute alcohol
remains a viable pharmacotherapeutic strategy to treat al-
cohol use disorders, particularly for individuals who are most
sensitive to these alcohol effects (Heilig et al., 2010). Although
the efficacy of classic neuroleptics remains limited by un-
desirable side effects, newer DA receptor antagonists that are
proposed to modulate the balance between tonic and phasic
DA levels, such as aripiprazole, or other classes of drugs that
impact dopaminergic neurotransmission indirectly, such as
ondansetron, may be more effective and behaviorally specific
(Edwards et al., 2011).
In terms of preclinical utility, although C57 mice voluntar-
ily consume alcohol, by most behavioral metrics they appear
less sensitive to its effects. Conversely, due to an inherent
taste aversion, DBA mice do not drink significant amounts of
alcohol but are more sensitive to its effects. For purposes of
preclinical therapeutics development, differences in behav-
ioral effects of alcohol on these two commonly used mouse
strains are important not only to considerations of drug
mechanisms but also to the development of personalized
therapy for alcohol use disorders in genetically distinct pa-
tient populations.
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